---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-012783"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2023-10-11T23:59:59+00:00"
generated_at: "2026-06-10T01:38:26.492408+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech announces 1-for-7 reverse share split effective October 11, 2023

## Summary
- Reverse split reduces outstanding shares from ~21.5M to ~3.07M; no change in proportional ownership.
- No fractional shares issued; fractions rounding per British Columbia law.
- Adjustments made to equity awards and warrants exercise prices and shares.
- Shareholder approval not required under British Columbia corporate law.
- Common shares continue trading under symbol EDSA with new CUSIP 27966L306.

## SEC filing metadata
- accession: 0001654954-23-012783
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2023-10-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000165495423012783/0001654954-23-012783-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000165495423012783/edsa_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-012783
- JSON: https://secwatch.observer/filing/0001654954-23-012783.json
- Plain text: https://secwatch.observer/filing/0001654954-23-012783.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.